Biography
Naim Alkhouri, M.D., currently serves as a Staff Physician with Digestive Disease Institute and Cleveland Clinic’s Children’s Hospital. Dr. Alkhouri is board certified in internal medicine and pediatrics. He completed his medical degree at the University of Damascus, Damascus, Syria. His post-graduate training includes a one-year internal medicine and pediatric internship followed by a three-year internal medicine and pediatric residency at Albert Einstein Medical Center in Philadelphia; a three-year pediatric gastroenterology, hepatology and nutrition fellowship at Cleveland Clinic; and finally, an Adult Transplant Hepatology fellowship at the Digestive Disease Institute, Cleveland Clinic. Dr. Alkhouri is a member of several professional organizations, including the American Association for the Study of Liver Disease; American Gastroenterology Association; American College of Gastroenterology; and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Among many research awards over the years, Dr. Alkhouri recently received the American College of Gastroenterology Junior Faculty Development Award to investigate volatile organic compounds in the breath of patients with liver disease. He also received the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Fellow Research Award for his prospective evaluation of the pediatric NAFLD fibrosis index and ELF markers in children with fatty liver disease. Dr. Alkhouri is an established clinical and basic researcher and has published multiple research articles in peer-reviewed journals, textbook chapters, as well as having contributed abstracts and presentations at a number of professional association meetings.
Research Interest
Dr. Alkhouri’s specialty interests include nonalcoholic fatty liver disease, viral hepatitis, autoimmune liver disease, metabolic liver disease, end stage liver disease, liver transplantation, and alpha-1 antitrypsin deficiency.
Publications
-
Viral Hepatitis C and Impact of Direct-Acting Antivirals on Liver Transplant
Short Communication: J Liver Disease Transplant
DOI:
Emily Richards